Studies showed that TRAF6-mediated AKT ubiquitination activates AKT to promote CRC growth, and TRAF6 promotes the EMT of HCC by enhancing AKT phosphorylation [32, 33]. Here, TRAF6 is linked to colorectal carcinoma.